Ondine Biomedical Inc., a frontrunner in light-activated antimicrobial technology to counter and manage hospital infections, draws attention to its robust operational achievements in H1 2024, revealing substantial strides and development in both its commercial and clinical initiatives.
Dominating the first half of 2024, this dynamic enterprise recorded an influx in the adoption of its revolutionary Steriwave®…